|1.||Wang, Jian-Zhi: 3 articles (08/2007 - 04/2004)|
|2.||Tian, Qing: 2 articles (11/2007 - 08/2007)|
|3.||Haneji, Tatsuji: 2 articles (08/2007 - 01/2005)|
|4.||Yoshida, Kaya: 2 articles (08/2007 - 01/2005)|
|5.||Okamura, Hirohiko: 2 articles (08/2007 - 01/2005)|
|6.||Morimoto, Hiroyuki: 2 articles (08/2007 - 01/2005)|
|7.||Ganote, C E: 2 articles (01/2001 - 07/2000)|
|8.||Armstrong, S C: 2 articles (01/2001 - 07/2000)|
|9.||Sun, Zhirong: 1 article (10/2015)|
|10.||Chen, Jiawei: 1 article (10/2015)|
10/01/2003 - "Calyculin A-induced PCC combined with multicolor FISH gives a new opportunity for analysis of the chromosomal constitution of G(1) and G(2) cancer cells and may find application in the study of the role of chromosome instability in cancer development."
12/01/1994 - "The tumor-promoting activity of okadaic acid and calyculin A may therefore not be by protection against apoptosis. "
11/01/2012 - "Calyculin A (Cal A) is a serine/threonine phosphatase inhibitor that is capable of inducing apoptosis in cancer cells. "
04/01/2004 - "Metaphase-like chromosomes were directly obtained following chromosome condensation using calyculin A (okadaic acid) from cytologic specimens of breast cancers sampled by fine needle. "
10/01/2003 - "In the fresh tumor specimens, Colcemid failed to result in metaphase formation, whereas a regimen of 80 nM calyculin A for 75 min, after only 2 days of culturing, resulted in a PCC index of 2-5%. "
|2.||Chromosome Aberrations (Chromosome Abnormalities)
12/01/2011 - "Our hypothesis in this study is that suboptimum calyculin A induction of PCC resulting in fuzzy compactness and/or shortened length chromosomes would decrease the detection sensitivity of numerical and structural chromosome aberrations such as small PCC rings and small excess fragments. "
12/01/2011 - "Optimization of calyculin A-induced premature chromosome condensation assay for chromosome aberration studies."
01/01/2007 - "Calyculin-A-induced premature chromosome condensation and fluorescent in situ hybridization were applied to study G2/M chromosomal aberrations. "
03/01/1999 - "A better understanding of the mechanism of action of calyculin A would help generalizing its use to study interphase chromosome aberrations."
12/01/2011 - "Calyculin A (50 nM) treatment for 30 min before the 48-h harvest of mitogen-stimulated human PBL is optimum for the formation of suitable chromosome morphology necessary to assess structural chromosome aberrations induced by exposure to radiation using the chemical induced-PCC assay. "
04/01/2011 - "Previous studies have reported that calyculin A (CA), a selective inhibitor of protein phosphatase (PP)-2A and PP-1, impairs axonal transport in neuroblastoma N2a cells. "
04/01/2004 - "Employing human neuroblastoma cells, we found that 10 nM calyculin A (CA), a selective inhibitor of PP-2A and PP-1, significantly increased phosphorylation and accumulation of neurofilament (NF) in the cells. "
08/01/2007 - "In the present study, we observed a selective inhibition of PP-2A and PP-1 with Calyculin A (CA) not only caused hyperphosphorylation of cytoskeletal proteins, but also impaired the transport of pEGFP-labeled neurofilament-M subunit in the axon-like processes of neuroblastoma N2a cells and resulted in accumulation of neurofilament in the cell bodies. "
09/01/2004 - "We have found recently that melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity. "
04/01/2004 - "Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity."
|4.||Osteosarcoma (Osteogenic Sarcoma)
08/01/2007 - "Calyculin A induces apoptosis and stimulates phosphorylation of p65NF-kappaB in human osteoblastic osteosarcoma MG63 cells."
01/01/1999 - "In a previous study, we demonstrated that the protein phosphatase inhibitors, okadaic acid and calyculin A, induced apoptosis in human osteosarcoma cell lines, Saos-2 and MG63 cells. "
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/01/2005 - "The purpose of this study was to examine the expression of PTEN and EGR-1 and the phosphorylation status of EGR-1 and Akt in calyculin A-treated human squamous carcinoma cells (SCCTF). "
07/01/1999 - "To determine whether protein phosphorylation and dephosphorylation can affect apoptosis in oral epithelial cells we examined the effects of protein phosphatase inhibitors, okadaic acid (OA) and calyculin A (CA), on cultured human oral squamous carcinoma (SCC) cell line, SCC-25 cells. "
|2.||Phosphoprotein Phosphatases (Phosphatases, Protein)
|9.||Phosphoric Monoester Hydrolases (Phosphatases)
|2.||Vasectomy (Vas Occlusion)
|3.||Drug Therapy (Chemotherapy)